Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 results.

Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 results.

Management of recurrent Hepatitis C virus (HCV) infection following liver transplantation remains a major challenge. In non-transplanted HCV genotype 1 patients, the introduction of protease inhibitor-based regimens has significantly increased the rate of sustained virological response. In this foll...

Full description

Bibliographic Details
Main Authors: Christoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, Silvio Nadalin, Alfred Königsrainer, Nisar P Malek, Christoph P Berg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3827217?pdf=render

Internet

http://europepmc.org/articles/PMC3827217?pdf=render

Similar Items